Ernexa Therapeutics Inc. Operating Expenses
Ernexa Therapeutics Inc. (ERNA) reported Operating Expenses of $4.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- Ernexa Therapeutics Inc. operating expenses for the quarter ending 2026-06-30 was $4.10M, a 64.09% increase year-over-year.
- Ernexa Therapeutics Inc. operating expenses for the quarter ending 2026-03-31 was $5.59M, a 104.76% increase year-over-year.
- Ernexa Therapeutics Inc. operating expenses for the quarter ending 2025-12-31 was $2.09M, a 22.39% decline year-over-year.
- Ernexa Therapeutics Inc. operating expenses for the quarter ending 2025-09-30 was $1.99M, a 28.97% decline year-over-year.
- Ernexa Therapeutics Inc. operating expenses for fiscal 2025 was $9.32M, a 42.33% decline from fiscal 2024.
- Ernexa Therapeutics Inc. operating expenses for fiscal 2024 was $16.16M, a 22.93% decline from fiscal 2023.
- Ernexa Therapeutics Inc. operating expenses for fiscal 2023 was $20.97M, a 36.88% decline from fiscal 2022.
- Ernexa Therapeutics Inc. operating expenses for fiscal 2022 was $33.22M, a 70.79% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.10M 10-Q · filed 2026-08-06 | $9.69M 10-Q · filed 2026-08-06 | $11.79M derived: sum of 3 quarters · filed 2026-08-06 | $13.78M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $5.59M 10-Q · filed 2026-05-11 | $7.68M derived: sum of 2 quarters · filed 2026-05-11 | $9.68M derived: sum of 3 quarters · filed 2026-05-11 | $12.18M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $4.09M derived: sum of 2 quarters · filed 2026-03-13 | $6.59M derived: sum of 3 quarters · filed 2026-08-06 | $9.32M 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | $1.99M 10-Q · filed 2025-11-07 | $4.49M derived: sum of 2 quarters · filed 2026-08-06 | $7.22M 10-Q · filed 2025-11-07 | $9.92M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $2.50M 10-Q · filed 2026-08-06 | $5.23M 10-Q · filed 2026-08-06 | $7.93M derived: sum of 3 quarters · filed 2026-08-06 | $10.73M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $2.73M 10-Q · filed 2026-05-11 | $5.43M derived: sum of 2 quarters · filed 2026-05-11 | $8.23M derived: sum of 3 quarters · filed 2026-05-11 | $13.12M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $5.50M derived: sum of 2 quarters · filed 2026-03-13 | $10.39M derived: sum of 3 quarters · filed 2026-03-13 | $16.16M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | $2.81M 10-Q · filed 2025-11-07 | $7.69M derived: sum of 2 quarters · filed 2025-11-07 | $13.46M 10-Q · filed 2025-11-07 | $19.18M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | $4.88M 10-Q · filed 2025-08-13 | $10.66M 10-Q · filed 2025-08-13 | $16.37M derived: sum of 3 quarters · filed 2025-08-13 | $21.81M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $5.77M 10-Q · filed 2025-05-07 | $11.49M derived: sum of 2 quarters · filed 2025-05-07 | $16.93M derived: sum of 3 quarters · filed 2025-05-07 | $21.47M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | $5.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $11.15M derived: sum of 2 quarters · filed 2025-03-12 | $15.70M derived: sum of 3 quarters · filed 2025-03-12 | $20.97M 10-K · filed 2025-03-12 | ||||
| 2023-09-30 | $5.44M 10-Q · filed 2024-11-12 | $9.98M derived: sum of 2 quarters · filed 2024-11-12 | $15.25M 10-Q · filed 2024-11-12 | $19.99M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $4.55M 10-Q · filed 2024-08-13 | $9.81M 10-Q · filed 2024-08-13 | $9.87M 10-Q · filed 2023-08-11 | $14.55M derived: sum of 3 quarters · filed 2024-08-13 | $22.86M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $5.27M 10-Q · filed 2024-05-14 | $5.32M 10-Q · filed 2023-05-11 | $10.00M derived: sum of 2 quarters · filed 2024-05-14 | $18.31M derived: sum of 3 quarters · filed 2024-05-14 | $32.19M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $4.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $13.04M derived: sum of 2 quarters · filed 2024-03-14 | $26.92M derived: sum of 3 quarters · filed 2024-03-14 | $33.22M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $8.30M 10-Q · filed 2023-11-13 | $22.18M derived: sum of 2 quarters · filed 2023-11-13 | $28.48M 10-Q · filed 2023-11-13 | $37.00M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $13.88M 10-Q · filed 2023-08-11 | $20.18M 10-Q · filed 2023-08-11 | $28.70M derived: sum of 3 quarters · filed 2023-08-11 | $114.97M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $6.30M 10-Q · filed 2023-05-11 | $14.82M derived: sum of 2 quarters · filed 2023-05-11 | $101.09M derived: sum of 3 quarters · filed 2023-05-11 | $111.11M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $8.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $94.80M derived: sum of 2 quarters · filed 2023-03-20 | $104.81M derived: sum of 3 quarters · filed 2023-03-20 | $113.73M 10-K · filed 2023-03-20 | $113.55M 10-K · filed 2022-04-15 | |||
| 2021-09-30 | $86.28M 10-Q · filed 2022-11-14 | $86.33M 10-Q · filed 2021-11-12 | $96.29M derived: sum of 2 quarters · filed 2022-11-14 | $105.21M 10-Q · filed 2022-11-14 | $104.45M 10-Q · filed 2021-11-12 | $107.42M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $10.01M 10-Q · filed 2022-08-11 | $10.01M 10-Q · filed 2021-08-13 | $18.93M 10-Q · filed 2022-08-11 | $18.11M 10-Q · filed 2021-08-13 | $21.14M derived: sum of 3 quarters · filed 2022-08-11 | $23.15M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $8.92M 10-Q · filed 2022-07-01 | $8.10M 10-Q · filed 2021-05-17 | $11.13M derived: sum of 2 quarters · filed 2022-07-01 | $13.14M derived: sum of 3 quarters · filed 2022-07-01 | $15.15M derived: sum of 4 quarters · filed 2022-07-01 | |||
| 2020-12-31 | $2.21M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-01 | $4.21M derived: sum of 2 quarters · filed 2022-07-01 | $6.23M derived: sum of 3 quarters · filed 2022-07-01 | $7.25M 10-K/A · filed 2022-07-01 | $12.11M 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $2.01M 10-Q · filed 2021-11-12 | $2.90M 10-Q · filed 2020-11-13 | $4.03M derived: sum of 2 quarters · filed 2021-11-12 | $5.04M 10-Q · filed 2021-11-12 | $10.20M 10-Q · filed 2020-11-13 | $11.44M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $2.02M 10-Q · filed 2021-08-13 | $2.39M 10-Q · filed 2020-08-07 | $3.03M 10-Q · filed 2021-08-13 | $7.30M 10-Q · filed 2020-08-07 | $9.43M derived: sum of 3 quarters · filed 2021-08-13 | $14.32M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $1.01M 10-Q · filed 2021-05-17 | $4.92M 10-Q · filed 2020-05-20 | $7.41M derived: sum of 2 quarters · filed 2021-05-17 | $12.31M derived: sum of 3 quarters · filed 2021-05-17 | $17.53M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $6.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $11.29M derived: sum of 2 quarters · filed 2021-03-11 | $16.52M derived: sum of 3 quarters · filed 2021-03-11 | $21.57M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $4.90M 10-Q · filed 2020-11-13 | $10.12M derived: sum of 2 quarters · filed 2020-11-13 | $15.17M 10-Q · filed 2020-11-13 | $20.92M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $5.23M 10-Q · filed 2020-08-07 | $10.28M 10-Q · filed 2020-08-07 | $16.02M derived: sum of 3 quarters · filed 2020-08-07 | $21.66M derived: sum of 4 quarters · filed 2020-08-07 | ||||
| 2019-03-31 | $5.05M 10-Q · filed 2020-05-20 | $10.79M derived: sum of 2 quarters · filed 2020-05-20 | $16.43M derived: sum of 3 quarters · filed 2020-05-20 | $22.11M derived: sum of 4 quarters · filed 2020-05-20 | ||||
| 2018-12-31 | $5.75M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $11.38M derived: sum of 2 quarters · filed 2020-03-19 | $17.06M derived: sum of 3 quarters · filed 2020-03-19 | $23.13M 10-K · filed 2020-03-19 | ||||
| 2018-09-30 | $5.63M 10-Q · filed 2019-11-01 | $11.31M derived: sum of 2 quarters · filed 2019-11-01 | $17.39M 10-Q · filed 2019-11-01 | $23.17M derived: sum of 4 quarters · filed 2019-11-01 | ||||
| 2018-06-30 | $5.68M 10-Q · filed 2019-08-12 | $11.75M 10-Q · filed 2019-08-12 | $17.54M derived: sum of 3 quarters · filed 2019-08-12 | $22.79M derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | $6.07M 10-Q · filed 2019-05-14 | $11.86M derived: sum of 2 quarters · filed 2019-05-14 | $17.11M derived: sum of 3 quarters · filed 2019-05-14 | $22.68M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $11.04M derived: sum of 2 quarters · filed 2019-03-22 | $16.61M derived: sum of 3 quarters · filed 2019-03-22 | $22.68M 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | $5.25M 10-Q · filed 2018-11-09 | $10.83M derived: sum of 2 quarters · filed 2018-11-09 | $16.89M 10-Q · filed 2018-11-09 | $23.17M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | $5.58M 10-Q · filed 2018-08-06 | $11.64M 10-Q · filed 2018-08-06 | $17.92M derived: sum of 3 quarters · filed 2018-08-06 | $23.78M derived: sum of 4 quarters · filed 2018-08-06 | ||||
| 2017-03-31 | $6.07M 10-Q · filed 2018-05-11 | $12.35M derived: sum of 2 quarters · filed 2018-05-11 | $18.20M derived: sum of 3 quarters · filed 2018-05-11 | $24.30M derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | $6.28M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $12.14M derived: sum of 2 quarters · filed 2018-03-09 | $18.24M derived: sum of 3 quarters · filed 2018-03-09 | $24.59M 10-K · filed 2018-03-09 | ||||
| 2016-09-30 | $5.86M 10-Q · filed 2017-11-08 | $11.96M derived: sum of 2 quarters · filed 2017-11-08 | $18.31M 10-Q · filed 2017-11-08 | $25.73M derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | $6.10M 10-Q · filed 2017-08-04 | $12.45M 10-Q · filed 2017-08-04 | $19.88M derived: sum of 3 quarters · filed 2017-08-04 | $27.27M derived: sum of 4 quarters · filed 2017-08-04 | ||||
| 2016-03-31 | $6.35M 10-Q · filed 2017-05-04 | $13.77M derived: sum of 2 quarters · filed 2017-05-04 | $21.17M derived: sum of 3 quarters · filed 2017-05-04 | $29.83M derived: sum of 4 quarters · filed 2017-05-04 | ||||
| 2015-12-31 | $7.42M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $14.82M derived: sum of 2 quarters · filed 2017-03-09 | $23.48M derived: sum of 3 quarters · filed 2017-03-09 | $31.41M 10-K · filed 2017-03-09 | ||||
| 2015-09-30 | $7.39M 10-Q · filed 2016-11-09 | $16.06M derived: sum of 2 quarters · filed 2016-11-09 | $23.99M 10-Q · filed 2016-11-09 | $32.25M derived: sum of 4 quarters · filed 2016-11-09 | ||||
| 2015-06-30 | $8.66M 10-Q · filed 2016-08-04 | $16.60M 10-Q · filed 2016-08-04 | $24.86M derived: sum of 3 quarters · filed 2016-08-04 | $32.14M derived: sum of 4 quarters · filed 2016-08-04 | ||||
| 2015-03-31 | $7.93M 10-Q · filed 2016-05-09 | $16.20M derived: sum of 2 quarters · filed 2016-05-09 | $23.48M derived: sum of 3 quarters · filed 2016-05-09 | $31.65M derived: sum of 4 quarters · filed 2016-05-09 | ||||
| 2014-12-31 | $8.26M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $15.54M derived: sum of 2 quarters · filed 2016-03-15 | $23.72M derived: sum of 3 quarters · filed 2016-03-15 | $30.79M 10-K · filed 2016-03-15 | ||||
| 2014-09-30 | $7.28M 10-Q · filed 2015-11-09 | $15.45M derived: sum of 2 quarters · filed 2015-11-09 | $22.52M 10-Q · filed 2015-11-09 | $29.50M derived: sum of 4 quarters · filed 2015-11-09 | ||||
| 2014-06-30 | $8.17M 10-Q · filed 2015-08-10 | $15.24M 10-Q · filed 2015-08-10 | $22.22M derived: sum of 3 quarters · filed 2015-08-10 | $27.98M derived: sum of 4 quarters · filed 2015-08-10 | ||||
| 2014-03-31 | $7.07M 10-Q · filed 2015-05-08 | $14.05M derived: sum of 2 quarters · filed 2015-05-08 | $19.81M derived: sum of 3 quarters · filed 2015-05-08 | $25.46M derived: sum of 4 quarters · filed 2015-05-08 | ||||
| 2013-12-31 | $6.98M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $12.74M derived: sum of 2 quarters · filed 2015-03-27 | $18.39M derived: sum of 3 quarters · filed 2015-03-27 | $24.87M 10-K · filed 2015-03-27 | ||||
| 2013-09-30 | $5.76M 10-Q · filed 2014-11-07 | $11.41M derived: sum of 2 quarters · filed 2014-11-07 | $17.89M 10-Q · filed 2014-11-07 | $23.34M derived: sum of 4 quarters · filed 2014-11-07 | ||||
| 2013-06-30 | $5.65M 10-Q · filed 2014-08-14 | $12.13M 10-Q · filed 2014-08-14 | $17.58M derived: sum of 3 quarters · filed 2014-08-14 | $23.53M derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | $6.48M 10-Q · filed 2014-05-15 | $11.94M derived: sum of 2 quarters · filed 2014-05-15 | $17.89M derived: sum of 3 quarters · filed 2014-05-15 | $24.55M derived: sum of 4 quarters · filed 2014-05-15 | ||||
| 2012-12-31 | $5.45M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $11.40M derived: sum of 2 quarters · filed 2014-03-31 | $18.06M derived: sum of 3 quarters · filed 2014-03-31 | $25.13M 10-K · filed 2014-03-31 | ||||
| 2012-09-30 | $5.95M 10-Q · filed 2013-11-14 | $12.61M derived: sum of 2 quarters · filed 2013-11-14 | $19.67M 10-Q · filed 2013-11-14 | $26.68M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | $6.66M 10-Q · filed 2013-08-14 | $13.72M 10-Q · filed 2013-08-14 | $20.73M derived: sum of 3 quarters · filed 2013-08-14 | $27.40M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $7.06M 10-Q · filed 2013-05-13 | $14.07M derived: sum of 2 quarters · filed 2013-05-13 | $20.74M derived: sum of 3 quarters · filed 2013-05-13 | $27.69M derived: sum of 4 quarters · filed 2013-05-13 | ||||
| 2011-12-31 | $7.01M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $13.68M derived: sum of 2 quarters · filed 2013-03-29 | $20.63M derived: sum of 3 quarters · filed 2013-03-29 | $27.15M 10-K · filed 2013-03-29 | ||||
| 2011-09-30 | $6.67M 10-Q · filed 2012-11-09 | $13.61M derived: sum of 2 quarters · filed 2012-11-09 | $20.13M 10-Q · filed 2012-11-09 | $26.19M derived: sum of 4 quarters · filed 2012-11-09 | ||||
| 2011-06-30 | $6.95M 10-Q · filed 2012-08-14 | $13.47M 10-Q · filed 2012-08-14 | $19.52M derived: sum of 3 quarters · filed 2012-08-14 | $25.87M derived: sum of 4 quarters · filed 2012-08-14 | ||||
| 2011-03-31 | $6.52M 10-Q · filed 2012-05-11 | $12.58M derived: sum of 2 quarters · filed 2012-05-11 | $18.93M derived: sum of 3 quarters · filed 2012-05-11 | $25.52M derived: sum of 4 quarters · filed 2012-05-11 | ||||
| 2010-12-31 | $6.06M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $12.41M derived: sum of 2 quarters · filed 2012-03-30 | $19.00M derived: sum of 3 quarters · filed 2012-03-30 | $25.63M 10-K · filed 2012-03-30 | ||||
| 2010-09-30 | $6.35M 10-Q · filed 2011-11-14 | $12.95M derived: sum of 2 quarters · filed 2011-11-14 | $19.58M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $6.60M 10-Q · filed 2011-08-12 | $13.23M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |